Latest News - Biotech - United States - Maryland

The Tailwind, a revolutionary new arm rehabilitation device for stroke survivors, will be unveiled by Kris Appel, founder of Encore Path, in Saginaw, Michigan, on Friday and Saturday, November 20 and 21, 2009, at Fashion Square Mall.

PROSSIS is now the exclusive representative of EMTEK, LLC. in MD, VA and DC. PROSSIS focuses on monitoring and control of environments, equipment and processes, and offers clients local support and expertise for their monitoring needs.

This free synthesis and purification of peptide libraries webinar examines synthesis of peptide libraries including synthesis of cyclic peptides employing a safety-catch linker, allowing production of diverse libraries for biological screening.

RNL Bio successfully cloned a small breed Pekingese commercially for the first time in the world.

RNL Bio successfully treated a horse with syndesmitis and it will return to race track soon.

RNL Bio made another breakthrough in dog cloning history. Two clones were born from a Beagle donor's stem cells instead of skin cells.

Intravenous delivery of adipose derived stem cells showed effects on liver function restoration

The world's first commercially cloned dogs were sent home last month. The company recommends pet owners to be prepared for dogs' sudden death by saving live cells while they are alive.

RNL's stem cell clinic is specialized in cell therapies for degenerative diseases and anti-aging treatments using intravenous injections of stem cells and accepting patients from North America and Europe.

RNL Bio offers an exceptional promotion for dog cloning at hugely discounted cost.

- Five clones from ‘Booger’ were born by world’s first commercial order. - The project completed in only 70 days, boasting the efficacy of the technology. - RNL starts to offer cloning service, world-wide.

RNL Bio has signed a licensing agreement with a Japanese biotech company for RNL's stem cell technology to establish stem cell banks and to sell the stem cell therapeutics in Japan

RNL Bio now offers a stem cell bank facility for hepatitis virus carriers to store their own stem cells for future treatment.

Scientists made a significant advance in differentiation of adult stem cells into hepatobiliary cells.

Trevigen's Cultrex® 24 Well Cell Invasion Assay kits quantify the degree to which invasive cells penetrate either basement membrane extract, collagen I, collagen IV, or laminin I, in vitro.

When exposed to oxidative radicals, 8-hydroxy-2’-deoxyguanosine (8-oxo-dG) is formed and can serve as a sensitive indicator of physiological and environmental damage to DNA.

The dead pet dog's cells were arrived in Seoul Korea for the world's fisrt commercial dog cloning project.

Trevigen launches HT PARP/Apoptosis Assays ideal for measuring the activity of PARP in a high-throughput, 96-well format.

RNL Bio partners with Seoul National University's Veterinary Medical Teaching Hospital to offer stem cell therapeutics for pets and even pet cloning

Trevigen announces the immediate availability of PathClear" Basement Membrane Extract in the Cultrex® product line. PathClear" BME is expected to be of special interest for research work requiring BME free from viruses, bacteria and mycoplasma.